300
Participants
Start Date
August 1, 2018
Primary Completion Date
April 30, 2031
Study Completion Date
April 30, 2031
RECRUITING
The Carolina Institute for Developmental Disabilities, Carrboro
RECRUITING
Emory University School of Medicine, Atlanta
RECRUITING
Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville
RECRUITING
Rush University Children's Hospital, Chicago
RECRUITING
Children's Hospital Colorado, Anschutz Medical Campus, Aurora
NOT_YET_RECRUITING
Cedars-Sinai Guerin Children's, Los Angeles
RECRUITING
Rady Children's Hospital, San Diego, San Diego
RECRUITING
Boston Children's Hospital, Boston
RECRUITING
Alberta Children's Hospital, Calgary
RECRUITING
BC Children's Hospital, Vancouver
RECRUITING
Children's Hospital of Eastern Ontario, Ottawa
University of California, San Diego
OTHER
Angelman Syndrome Biomarker & Outcome Measure Consortium (A-BOM)
UNKNOWN
Food and Drug Administration (FDA)
FED
Angelman Syndrome Foundation Canada
UNKNOWN
Foundation for Angelman Syndrome Therapeutics Canada
UNKNOWN
Foundation for Angelman Syndrome Therapeutics
UNKNOWN
Angelman Syndrome Foundation, Inc.
OTHER
Boston Children's Hospital
OTHER